Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Lipid-Based Nanoparticles for the Targeted Delivery of Anticancer Drugs: A Review Publisher Pubmed



Khodaverdi H1 ; Zeini MS2, 3 ; Moghaddam MM4 ; Vazifedust S5 ; Akbariqomi M4 ; Tebyaniyan H6
Authors
Show Affiliations
Authors Affiliations
  1. 1. National Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran
  2. 2. Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
  5. 5. Faculty of Veterinary Medicine, University of Urmia, Urmia, Iran
  6. 6. Islamic Azad University, Science and Research Branch, Tehran, Iran

Source: Current Drug Delivery Published:2022


Abstract

Cancer is one of the leading causes of mortality worldwide. Although chemotherapeutic agents have been effectively designed to increase the survival rates of some patients, the designed chemotherapeutic agents necessarily deliver toxic chemotherapeutic drugs to healthy tissues, resulting in serious side effects. Cancer cells can often acquire drug resistance after repeatedly administering current chemotherapeutic agents, restricting their efficacy. Given such obstacles, investigators have attempted to distribute chemotherapeutic agents using targeted drug delivery systems (DDSs), especially nanotechnology-based DDSs. The lipid-based nanoparticles (LBNPs) are a large and complex class of substances utilized to manage various diseases, especially cancers. Liposomes seem to be the most frequently employed LBNPs, owing to their high biocompatibility, bioactivity, stability, and flexibility. Solid lipid NPs and non-structured lipid carriers have lately received a lot of interest. In addition, several reports focused on novel therapies via LBNPs to manage various forms of cancer. In the present re-search, the latest improvements in applying LBNPs have been shown to deliver different therapeutic agents to cancerous cells and be a quite successful candidate in cancer therapy. © 2022 Bentham Science Publishers.
Other Related Docs
9. A Concise Review on Cancer Treatment Methods and Delivery Systems, Journal of Drug Delivery Science and Technology (2019)
16. Lipid-Based Nanoparticles for Drug Delivery Systems, Characterization and Biology of Nanomaterials for Drug Delivery: Nanoscience and Nanotechnology in Drug Delivery (2018)
19. Toxicity Concerns of Nanocarriers, Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes (2017)
21. Encapsulation: Controlled Drug Delivery, Principles of Biomaterials Encapsulation: Volume 2 (2023)
22. In Silico Activity of As1411 Aptamer Against Nucleolin of Cancer Cells, Iranian Journal of Blood and Cancer (2020)
24. Rgd-Engineered Nanoparticles As an Innovative Drug Delivery System in Cancer Therapy, Journal of Drug Delivery Science and Technology (2023)
28. Nps Loaded With Zoledronic Acid As an Advanced Tool for Cancer Therapy, Journal of Drug Delivery Science and Technology (2023)
35. Immunoregulation by Resveratrol; Implications for Normal Tissue Protection and Tumour Suppression, Clinical and Experimental Pharmacology and Physiology (2023)
38. Controlled/Localized Release and Nanotechnology, Nanoengineered Biomaterials for Advanced Drug Delivery (2020)